Osteoporosis and osteopenia can weaken bones over time, often before symptoms appear. For patients with inflammatory disease, long-term corticosteroid use, or prior fractures, bone health may need closer specialty care.
PACT Rheumatology provides osteoporosis treatment in Connecticut for patients who need bone density evaluation, medication management, fracture risk review, and prevention support.
New Patients Welcome | Hamden, Guilford & Orange, CT
Osteoporosis is a condition that causes bones to become weak and porous due to reduced bone density. This can increase the risk of fractures, often before a person notices any warning signs.
Osteoporosis is sometimes called a silent disease because many people do not know they have it until a fracture occurs. Common fracture sites include the hip, spine, and wrist.
About 10 million Americans have osteoporosis, and many more have low bone density that increases fracture risk.
Osteopenia means bone density is lower than normal but not yet at the level of osteoporosis. It is often considered an early warning sign for future bone loss.
Many people with osteopenia have no symptoms. With early evaluation, lifestyle changes, monitoring, and treatment when needed, progression to osteoporosis may be slowed or prevented.
Both osteopenia and osteoporosis involve reduced bone mineral density. The difference is severity, usually measured by a DEXA scan.
| Condition | What It Means | Typical T-Score |
| Normal bone density | Bone density is within the expected range | -1.0 or higher |
| Osteopenia | Bone density is below normal but not low enough for osteoporosis | Between -1.0 and -2.5 |
| Osteoporosis | Bone density is low enough to significantly increase fracture risk | -2.5 or lower |
Both conditions can be addressed with the right care plan. Early identification gives patients more options for protecting bone strength.
Osteoporosis often has no symptoms until a fracture occurs. Some patients only learn they have bone loss after a bone density test or a fracture from a minor fall.
Possible warning signs may include:
Common risk factors may include:
Patients with autoimmune or inflammatory diseases may need earlier-than-expected bone health monitoring, especially if corticosteroids are part of their treatment history.
A rheumatologist may treat osteoporosis when bone loss is associated with inflammatory or autoimmune disease, or long-term corticosteroid use.
Many rheumatology patients manage conditions such as rheumatoid arthritis, lupus, ankylosing spondylitis, or other diseases that may increase fracture risk. Bone health monitoring can be part of comprehensive rheumatology care.
Rheumatologists can prescribe, monitor, and adjust medications used to slow bone loss, build bone, or reduce fracture risk.
Nonsteroidal anti-inflammatory drugs and corticosteroids may be used for short-term relief of pain, swelling, or flares when appropriate.
DMARDs, such as methotrexate or hydroxychloroquine, may be used to reduce immune-driven inflammation and slow joint damage.
Biologic medications target specific parts of the immune system involved in inflammation. They may be recommended for moderate-to-severe RA or when other medications are not enough.
JAK inhibitors are oral targeted medications that may be considered for certain patients based on disease activity, treatment history, and overall health.
Follow-up visits and lab work allow your rheumatology team to monitor disease activity, medication response, and possible side effects.
Activity modification, movement strategies, and joint protection techniques may support daily function alongside medical treatment.
Rheumatoid arthritis can involve flares, periods of remission, and changes in symptoms. An ongoing care plan helps patients monitor these patterns and adjust treatment when needed.
Early and appropriate treatment may reduce the risk of joint damage. Some patients may also benefit from physical therapy, occupational therapy, or support with activity modifications.
RA is a chronic condition, but many patients can manage symptoms and maintain daily function with specialist care and regular monitoring.
Early diagnosis and treatment can reduce the risk of long-term joint damage.
Dr. Beth Valashinas, D.O., FACR, provides specialty care for rheumatoid arthritis and other inflammatory or autoimmune joint conditions.
PACT Rheumatology offers medication management, DMARD therapy, biologic therapy, infusion services, and ongoing monitoring.
PACT works with patients who have new symptoms, recent diagnoses, inadequate treatment response, or more complex disease activity.
Patients can access RA care in Hamden, Guilford, and Orange, with service to nearby communities such as New Haven, Milford, Branford, Wallingford, and North Haven.
As part of Physicians Alliance of Connecticut, PACT Rheumatology can coordinate with related specialists when RA affects more than the joints.
Early RA treatment can make a difference. If symptoms persist or joint inflammation is suspected, do not delay requesting an evaluation.
Rheumatoid arthritis is a chronic autoimmune disease that causes the immune system to attack the joints. This can lead to pain, swelling, stiffness, inflammation, and possible joint damage.
Early signs may include morning stiffness, pain and swelling in small joints, symptoms on both sides of the body, fatigue, low-grade fever, and symptoms that last longer than six weeks.
Yes. Rheumatoid arthritis is an autoimmune disease. The immune system mistakenly attacks healthy joint tissue, causing inflammation and joint symptoms.
RA may be diagnosed through symptom review, physical exam, bloodwork such as rheumatoid factor and anti-CCP, inflammation markers, and imaging such as X-rays, ultrasound, or MRI.
There is no current cure for RA, but treatment can reduce inflammation, manage symptoms, slow disease progression, and reduce the risk of joint damage.
The best treatment depends on disease activity, symptoms, test results, and treatment response. Options may include DMARDs, biologic therapy, JAK inhibitors, anti-inflammatory medication, and ongoing monitoring.
RA is an autoimmune inflammatory disease that can affect multiple joints and other body systems. Osteoarthritis is usually related to joint wear, cartilage changes, and mechanical stress.
Yes. PACT Rheumatology provides rheumatoid arthritis treatment in Connecticut at locations in Hamden, Guilford, and Orange.
PACT, LLC & PACT MSO, LLC
322 East Main Street, Suite 1B
Branford, CT 06405
PACT, LLC & PACT MSO, LLC
322 East Main Street, Suite 1B
Branford, CT 06405
